DSO & Corporate Sales

Selling to a DSO or corporate buyer

Overview

DSO and corporate sales reach valuations private-buyer deals can’t — but the headline multiple is rarely the most important number. Rollover-equity terms, post-closing employment commitments, operational autonomy, and the language of the restrictive covenants determine whether the deal feels like a successful exit five years later or a contractual trap. We negotiate against the institutional buyers daily; we know which terms are negotiable and which are standard.

What we handle

  • LOI negotiation with binding-vs-non-binding clauses set up to your advantage
  • APA and stock purchase agreement drafting and review
  • Rollover-equity structuring, vesting, and exit mechanics
  • Post-closing employment and clinical-services agreements
  • Non-compete and non-solicitation negotiation
  • MSA / management services agreements and PC / MSO structuring

Questions we'll work through with you

  • Will you retain ownership in the practice post-closing? If so, on what terms and what exit mechanism?
  • How long will you commit to clinical practice or executive role after closing?
  • What operational and clinical autonomy will you retain?
  • How will the non-compete and non-solicitation clauses constrain your next move?
Our Process

How Can Our Team Help You to Reach Your Goals

01

Pre-LOI (4–8 weeks)

Financial cleanup, EBITDA normalization to institutional standards, MSO/PC structure review and pre-deal cleanup if needed.
02

LOI (2–4 weeks)

DSO LOIs are more comprehensive and more aggressive than private-buyer LOIs. Rollover-equity terms, post-closing employment, non-compete scope, and management-services-agreement architecture all set here.
03

Due Diligence (8–12 weeks)

Institutional diligence — financial, legal, regulatory, IT, environmental. Multiple workstreams from multiple advisors.
04

Definitive Agreement (4–8 weeks)

Heavy document set: APA, MSA, employment agreement, rollover-equity documents, restrictive covenants. Each is negotiated against the institutional buyer’s standard package.

05

Closing (1 day, often coordinated with financing close)

Funds wire (cash portion), rollover-equity issuance, MSA effective date, employment agreement effective date.
06

Post-Closing (24 months and longer)

Seller commits to clinical and/or executive role for the agreed term. Earn-out and rollover-equity values resolve over multiple years. Restrictive covenants run through and beyond the employment term.